Name
mRNA Technology, Personalized Medicine and More
Time
9:45 AM - 10:14 AM
Session Type
Panel
Description

mRNA platforms are being employed to fight off COVID and future pathogens, and hold promise for fighting cancer. At the same time, personalized medicine is making possible ever-more targeted treatments for serious illnesses. Who benefits and who pays?

Speakers
Christopher M. Black, PhD - Merck & Co., Inc.
Angela Luong, PharmD - Pharmaceutical Strategies Group (PSG)
Kevin C. De Braganca, MD - Janssen Pharmaceuticals
Kristen Oliveira, MSN, FNP-C - Pfizer
Christopher M. Black, PhD Angela Luong, PharmD Kevin C. De Braganca, MD Kristen Oliveira, MSN, FNP-C